Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01426828 · FLOW

Participant flow

Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant · Source last updated 2020-12-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Arm A will receive the CD3/CD28 activated autologous lymphocytes intravenously and subcutaneous injections of "KLH only" vaccine. CD3/CD28: CD3/CD28 activated autologous lymphocytes intravenously
    id
    FG000
    title
    Arm A
  2. description
    Arm B will receive the CD3/CD28 activated autologous lymphocytes intravenously and subcutaneous injections of ID-KLH Vaccine Myeloma Immunoglobulin Idiotype Vaccine (id-KLH vaccine) CD3/CD28: CD3/CD28 activated autologous lymphocytes intravenously
    id
    FG001
    title
    Arm B
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        18
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        17
      2. group Id
        FG001
        num Subjects
        15
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        3
      type
      NOT COMPLETED
    title
    Overall Study Evaluations
  2. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        17
      2. group Id
        FG001
        num Subjects
        15
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        8
      2. group Id
        FG001
        num Subjects
        8
      comment
      Only those subjects that had sufficient PBMC samples from pre-vaccination (D0), and Day 30, Day 90 and Day 180 time points for NanoString gene expression analysis were included in the immune response analysis.
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        7
      type
      NOT COMPLETED
    title
    Immune Response Analysis
Complete source fields
groups
  1. description
    Arm A will receive the CD3/CD28 activated autologous lymphocytes intravenously and subcutaneous injections of "KLH only" vaccine. CD3/CD28: CD3/CD28 activated autologous lymphocytes intravenously
    id
    FG000
    title
    Arm A
  2. description
    Arm B will receive the CD3/CD28 activated autologous lymphocytes intravenously and subcutaneous injections of ID-KLH Vaccine Myeloma Immunoglobulin Idiotype Vaccine (id-KLH vaccine) CD3/CD28: CD3/CD28 activated autologous lymphocytes intravenously
    id
    FG001
    title
    Arm B
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        22
      2. group Id
        FG001
        num Subjects
        18
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        17
      2. group Id
        FG001
        num Subjects
        15
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        3
      type
      NOT COMPLETED
    title
    Overall Study Evaluations
  2. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        17
      2. group Id
        FG001
        num Subjects
        15
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        8
      2. group Id
        FG001
        num Subjects
        8
      comment
      Only those subjects that had sufficient PBMC samples from pre-vaccination (D0), and Day 30, Day 90 and Day 180 time points for NanoString gene expression analysis were included in the immune response analysis.
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        7
      type
      NOT COMPLETED
    title
    Immune Response Analysis

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice